SCHEMBL6944749

SCHEMBL6944749

COC(=O)N(Cc1ccc(C(=O)OC(C)(C)C)cc1Br)C(=O)OC(C)(C)C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 1/20 0.39
P4HB P07237 1/20 0.37
CA12 O43570 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
CA9 Q16790 1/20 0.36
CA14 Q9ULX7 1/20 0.36
MTNR1A P48039 1/20 0.35
MTNR1B P49286 1/20 0.35
GABRA1 P14867 1/20 0.35
GABRG2 P18507 1/20 0.35
GABRB3 P28472 1/20 0.35
GABRA3 P34903 1/20 0.35
GABRA2 P47869 1/20 0.35
SLC7A5 Q01650 1/20 0.34
STAT3 P40763 2/20 0.34
ALOX15 P16050 1/20 0.34
SSTR4 P31391 1/20 0.33
BUB1 O43683 1/20 0.33
HDAC3 O15379 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20649289 0.93 NOTUM (0.47) NOTUMP4HBCA12CA1CA2
SCHEMBL7445333 0.81 VCAM1 (0.44) NPC1MAPTRAB9ALMNAALDH1A1
SCHEMBL6948372 0.78 ALOX15 (0.42) CA12CA1CA2CA9CA14
SCHEMBL3526985 0.77 CA12 (0.43) NOTUMP4HBCA12CA1CA2
SCHEMBL6652570 0.75 HDAC1 (0.43) SLC7A5SSTR4HDAC3HDAC1HDAC2
SCHEMBL28847028 0.75 ABCB1 (0.38) SSTR4
SCHEMBL21876581 0.75 NR4A2 (0.39) NPC1MAPTRAB9AALDH1A1
SCHEMBL6540511 0.75 TRPA1 (0.39) NOTUMCA12CA1CA2CA9
SCHEMBL6950153 0.74 HDAC10 (0.43) NOTUMP4HBCA12CA1CA2
SCHEMBL6948552 0.74 KMT2A (0.44) MAPTLMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0674623-B1 BICYCLIC FIBRINOGEN ANTAGONISTS SMITHKLINE BEECHAM CORP (US) 2003-04-09 EP disclosed
US-6403578-B1 ANTICOAGULANTS, CARDIOVASCULAR DISORDERS SMITHKLINE BEECHAM CORPORATION 2002-06-11 US disclosed